+499.5%
MRNA vs SN
+46.4%
+453.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.0% | -1.2% | -2.2% |
| 7D | +5.5% | -9.3% | +14.8% | +6.1% |
| 30D | +158.7% | -4.8% | +163.5% | +158.4% |
| 3M | +182.1% | +40.4% | +141.7% | +157.7% |
| 6M | +151.8% | +50.9% | +100.9% | +123.7% |
| YTD | +393.6% | +54.9% | +338.6% | +334.3% |
| 1Y | +499.5% | +43.0% | +456.4% | +377.7% |
| All | +499.5% | +46.4% | +453.1% | +377.7% |
Cumulative growth
Daily Returns
Daily percentage return beside SN.
Daily Out/Under-Performance
Portfolio return minus SN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling